By:AAPerry

S.B.ANo.A199

A BILL TO BE ENTITLED
AN ACT

1
2

relating

to

the

designation

of

certain

synthetic

compounds

Penalty Group 2 or 2-A of the Texas Controlled Substances Act.

to

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTIONA1.AASections 481.002(5) and (6), Health and Safety

Code, are amended to read as follows:

(5)AA"Controlled

drug,

an

substance"

adulterant,

and

means
a

substance,

including

dilutant,

listed

in

Schedules I through V or Penalty Group [Groups] 1, 1-A, [or] 2, 2-A,

10

3, or [through] 4.

The term includes the aggregate weight of any

11

mixture,

or

12

substance.

solution,

other

substance

containing

controlled

(6)AA"Controlled substance analogue" means:

13

(A)AAa

14

substance

with

chemical

structure

15

substantially similar to the chemical structure of a controlled

16

substance in Schedule I or II or Penalty Group 1, 1-A, [or] 2, or

17

2-A; or

18

(B)AAa substance specifically designed to produce

19

an effect substantially similar to, or greater than, the effect of a

20

controlled substance in Schedule I or II or Penalty Group 1, 1-A,

21

[or] 2, or 2-A.

22
23
24

SECTIONA2.AASection 481.103(a), Health and Safety Code, is

amended to read as follows:
(a)AAPenalty Group 2 consists of:

84R1124 JSC-D

S.B.ANo.A199
(1)AAany

quantity

of

the

following

hallucinogenic

substances, their salts, isomers, and salts of isomers, unless

specifically excepted, if the existence of these salts, isomers,

and

designation:

salts

of

isomers

is

possible

within

the

specific

alpha-ethyltryptamine;

alpha-methyltryptamine;

5-(2-aminopropyl)benzofuran (5-APB);

6-(2-aminopropyl)benzofuran (6-APB);
5-(2-aminopropyl)-2,3-dihydrobenzofuran

10
11

(5-APDB);
6-(2-aminopropyl)-2,3-dihydrobenzofuran

12
13

(6-APDB);

14
15

5-(2-aminopropyl)indole

(Trade

or

other

names:

6-(2-aminopropyl)indole

(Trade

or

other

names:

5-IT, 5-API);

16
17

chemical

6-IT, 6-API);

18

Benzothiophenylcyclohexylpiperidine (BTCP);

19

4-bromo-2, 5-dimethoxyamphetamine (some trade or

20

other names:

21

4-bromo-2, 5-DMA);

4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;

22

4-bromo-2, 5-dimethoxyphenethylamine;

23

8-bromo-alpha-methyl-benzo[1,2-b:4,5-b ]difuran-

24

4-ethanamine (Trade or other name: Bromo-DragonFLY);

25

Bufotenine (some trade and other names:

3-(beta-

26

Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5-

27

indolol;

N,

N-dimethylserotonin;

5-hydroxy-N,

N-

S.B.ANo.A199
1

dimethyltryptamine; mappine);

Desoxypipradrol (2-benzhydrylpiperidine);

Diethyltryptamine (some trade and other names:

N-Diethyltryptamine, DET);
2,

5
6

(some

trade

other

name: DOET);
2,

5-dimethoxy-4-(n)-propylthiophenethylamine

(trade or other name: 2C-T-7);

11

Dimethyltryptamine (trade or other name:

12

Diphenylprolinol

13

or

2, 5-dimethoxy-4-ethylamphetamine (trade or other

9
10

5-dimethoxyamphetamine

names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);

7
8

N,

DMT);

(diphenyl(pyrrolidin-2-yl)

methanol, D2PM);
Dronabinol

14

(synthetic)

in

sesame

oil

and

15

encapsulated in a soft gelatin capsule in a U.S. Food and Drug

16

Administration approved drug product (some trade or other names for

17

Dronabinol:

18

trimethyl-3-pentyl-6H-

19

(trans)- tetrahydrocannabinol);

(a6aR-trans)-6a,7,8,10a-tetrahydrodibenzo

[b,d]pyran-1-ol

or

6,6,

9-

(-)-delta-9-

Ethylamine Analog of Phencyclidine (some trade or

20
21

other

22

phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,

23

cyclohexamine, PCE);

24
25
26
27

names:

N-ethyl-1-phenylcyclohexylamine,

(1-

2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
(Trade or other name: methoxetamine);
Ibogaine (some trade or other names:

7-Ethyl-6,

6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-

S.B.ANo.A199
1

pyrido [1 , 2 :1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);

5-iodo-2-aminoindane (5-IAI);

Mescaline;

5-methoxy-N,

N-diisopropyltryptamine

(5-MeO-DIPT);

5-methoxy-N, N-diallyltryptamine (5MeO-DALT);

5-methoxy-3, 4-methylenedioxy amphetamine;

4-methoxyamphetamine (some trade or other names:

9
10

4-methoxy-alpha-methylphenethylamine;

paramethoxyamphetamine;

PMA);

11

4-methoxymethamphetamine (PMMA);

12

2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone

13

(Trade or other names: 2-MeO-ketamine; methoxyketamine);

14
15

1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,

PPMP);

16

4-methyl-2,

5-dimethoxyamphetamine

17

and

18

methylphenethylamine; "DOM"; "STP");

other

names:AA4-methyl-2,

(some

trade

5-dimethoxy-alpha-

19

3,4-methylenedioxy methamphetamine (MDMA, MDM);

20

3,4-methylenedioxy amphetamine;

21

3,4-methylenedioxy

22

N-ethylamphetamine

(Also

known as N-ethyl MDA);

23

5,6-methylenedioxy-2-aminoindane (MDAI);

24

Nabilone (Another name for nabilone:

(+)-trans-

25

3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,

26

6-dimethyl-9H-dibenzo[b,d] pyran-9-one;

27

N-benzylpiperazine

(some

trade

or

other

names:

S.B.ANo.A199
1

BZP; 1-benzylpiperazine);

N-ethyl-3-piperidyl benzilate;

N-hydroxy-3,4-methylenedioxyamphetamine

known as N-hydroxy MDA);

4-methylaminorex;

N-methyl-3-piperidyl benzilate;

O-Acetylpsilocin

(Also

(Trade

or

other

name:

4-Aco-DMT);

Parahexyl (some trade or other names:

3-Hexyl-1-

10

hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]

11

pyran; Synhexyl);

12

1-Phenylcyclohexylamine;

13

1-Piperidinocyclohexanecarbonitrile (PCC);

14

Psilocin;

15

Psilocybin;

16

Pyrrolidine Analog of Phencyclidine (some trade

17

or other names:

1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);

18

Tetrahydrocannabinols, other than marihuana, and

19

synthetic equivalents of the substances contained in the plant, or

20

in the resinous extractives of Cannabis, or synthetic substances,

21

derivatives, and their isomers with similar chemical structure and

22

pharmacological activity such as:

23
24
25
26
27

delta-1 cis or trans tetrahydrocannabinol,

and their optical isomers;
delta-6 cis or trans tetrahydrocannabinol,
and their optical isomers;
delta-3,

cis

or

trans

S.B.ANo.A199
1

tetrahydrocannabinol, and its optical isomers;

compounds of these structures, regardless of

numerical designation of atomic positions, since nomenclature of

these substances is not internationally standardized;

Thiophene Analog of Phencyclidine (some trade or

5
6

other names:

1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl

Analog of Phencyclidine; TPCP, TCP);

1-pyrrolidine (some trade or other name: TCPy);

1-(3-trifluoromethylphenyl)piperazine

10

other name:

(trade

or

TFMPP); and
3,4,5-trimethoxy amphetamine;

11

(2)AAPhenylacetone

12
13

Phenyl-2-propanone;

14

ketone);

15

P2P,

(some

Benzymethyl

trade

or

ketone,

other

names:

methyl

benzyl

(3)AAunless specifically excepted or unless listed in

16

another

17

preparation that contains any quantity of the following substances

18

having

19

stimulant effect on the central nervous system:

20

Penalty

Group,

potential

for

material,

abuse

2-amino-5-phenyl-2-oxazoline;

22

phenyl-2-oxazolamine);

24
25

associated

with

mixture,

depressant

Aminorex (some trade or other names:

21

23

compound,

Amphetamine,

or

or

aminoxaphen;

4,5-dihydro-5-

its

salts,

optical

isomers,

and

salts of optical isomers;

Cathinone (some trade or other names:

26

phenyl-1-propanone,

27

aminopropiophenone);

alpha-aminopropiophenone,

2-amino-12-

S.B.ANo.A199
1

Etaqualone and its salts;

Etorphine Hydrochloride;

Fenethylline and its salts;

Lisdexamfetamine, including its salts, isomers,

and salts of isomers;

Mecloqualone and its salts;

Methaqualone and its salts;

Methcathinone

methylamino-propiophenone;

(some

trade

or

other

names:

2-

alpha-(methylamino)propriophenone;

10

2-(methylamino)-1-phenylpropan-1-one;

11

methylaminopropriophenone;

12

methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR

13

1431);

monomethylpropion;

ephedrone,

N-

N-Ethylamphetamine, its salts, optical isomers,

14
15

alpha-N-

and salts of optical isomers; and

N,N-dimethylamphetamine

16
17

names:

18

N,N,alpha-trimethylphenethylamine),

19

and salts of optical isomers; and

(some

trade

or

other

N,N,alpha-trimethylbenzeneethaneamine;

(4)AAany

20

compound

its

salts,

structurally

optical

derived

21

2-aminopropanal

22

monocyclic or fused-polycyclic ring system, including:

23

by

substitution

at

the

isomers,

1-position

from

with

any

(A)AAcompounds further modified by:

24

(i)AAsubstitution in the ring system to any

25

extent

26

hydroxyl,

27

substituted in the ring system by other substituents;

(including
or

alkyl,

halide

alkoxy,

substituents),

alkylenedioxy,
whether

or

haloalkyl,
not

further

S.B.ANo.A199
(ii)AAsubstitution at the 3-position with an

1
2

acyclic alkyl substituent; or

(iii)AAsubstitution at the 2-amino nitrogen

atom with alkyl, [or] dialkyl, benzyl, or methoxybenzyl groups, or

inclusion of the 2-amino nitrogen atom in a cyclic structure; and

(B)AAby example, compounds such as:

4-Methoxymethcathinone

7
8

4-Methylmethcathinone

as

(Also

known

as

Mephedrone);
3,4-Dimethylmethcathinone

11
12

known

Methedrone);

9
10

(Also

(Also

known

as

3,4-DMMC);

13

3-Fluoromethcathinone (Also known as 3-FMC);

14

4-Fluoromethcathinone

15

24
25
26
27

(Also

3,4-Methylenedioxypyrovalerone

(Also

known

alpha-Pyrrolidinopentiophenone

(Also

known

NaphthylpyrovaleroneAA(Also

known

as

as alpha-PVP);

22
23

3,4-Methylenedioxy-N-methylcathinone

as MDPV);

20
21

as

known as Methylone);

18
19

known

Flephedrone);

16
17

(Also

Naphyrone);
beta-Keto-N-methylbenzodioxolylpropylamine
(Also known as Butylone);
beta-Keto-N-methylbenzodioxolylpentanamine
(Also known as Pentylone);

S.B.ANo.A199
beta-Keto-Ethylbenzodioxolylbutanamine

1
2

(Also known as Eutylone); and

3,4-methylenedioxy-N-ethylcathinone

3
4
5
6
7

(Also

known as Ethylone).
SECTIONA3.AASection

481.1031,

Health

and

Safety

Code,

is

amended to read as follows:

Sec.A481.1031.AAPENALTY

GROUP

2-A.AAPenalty

Group

2-A

consists of any quantity of a synthetic chemical compound that is a

cannabinoid receptor agonist and mimics the pharmacological effect

10

of naturally occurring cannabinoids, including:

11

naphthoylindoles

structurally

derived

from

12

3-(1-naphthoyl)indole

13

nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl,

14

cycloalkylmethyl,

15

methyl,

16

(tetrahydropyran-4-yl)methyl,

17

or 2-(4-morpholinyl)ethyl, whether or not further substituted in

18

the indole ring to any extent, whether or not substituted in the

19

napthyl ring to any extent, including:

with

or

without

cycloalkylethyl,

cyanoalkyl,

20

AM-2201;

21

JWH-004;

22

JWH-007;

23

JWH-009;

24

JWH-015;

25

JWH-016;

26

JWH-018;

27

JWH-019;

[by]

substitution

at

the

(N-methylpiperidin-2-yl)

(N-methylpyrrolidin-2-yl)methyl,
((N-methyl)-3-morpholinyl)methyl,

S.B.ANo.A199
1

JWH-020;

JWH-046;

JWH-047;

JWH-048;

JWH-049;

JWH-050;

JWH-073;

JWH-076;

JWH-079;

10

JWH-080;

11

JWH-081;

12

JWH-082;

13

JWH-083;

14

JWH-093;

15

JWH-094;

16

JWH-095;

17

JWH-096;

18

JWH-097;

19

JWH-098;

20

JWH-099;

21

JWH-100;

22

JWH-116;

23

JWH-122;

24

JWH-148;

25

JWH-149;

26

JWH-153;

27

JWH-159;

10

S.B.ANo.A199
1

JWH-164;

JWH-165;

JWH-166;

JWH-180;

JWH-181;

JWH-182;

JWH-189;

JWH-193;

JWH-198;

10

JWH-200;

11

JWH-210;

12

JWH-211;

13

JWH-212;

14

JWH-213;

15

JWH-234;

16

JWH-235;

17

JWH-239;

18

JWH-240;

19

JWH-241;

20

JWH-242;

21

JWH-258;

22

JWH-259;

23

JWH-260;

24

JWH-262;

25

JWH-267;

26

JWH-386;

27

JWH-387;

11

S.B.ANo.A199
1

JWH-394;

JWH-395;

JWH-397;

JWH-398;

JWH-399;

JWH-400;

JWH-412;

JWH-413; and

JWH-414;
naphthylmethylindones

10

structurally

derived

from

11

1H-indol-3-yl-(1-naphthyl)methane

12

substitution at the nitrogen atom of the indole ring by alkyl,

13

haloalkyl,

14

(N-methylpiperidin-2-yl)methyl, cyanoalkyl, (N-methylpyrrolidin-

15

2-yl)methyl,

16

morpholinyl)methyl,

17

further substituted in the indole ring to any extent, whether or not

18

substituted in the naphthyl ring to any extent, including:

alkenyl,

with

or

cycloalkylmethyl,

(tetrahydropyran-4-yl)methyl,
or

2-(4-morpholinyl)ethyl,

19

JWH-175;

20

JWH-184;

21

JWH-185;

22

JWH-192;

23

JWH-194;

24

JWH-195;

25

JWH-196;

26

JWH-197; and

27

JWH-199;

12

without

[by]

cycloalkylethyl,

((N-methyl)-3whether

or

not

S.B.ANo.A199
1

naphthoylpyrroles

structurally

derived

from

3-(1-naphthoyl)pyrrole with or without [by] substitution at the

nitrogen atom of the pyrrole ring by alkyl, haloalkyl,

cycloalkylmethyl,

methyl,

(tetrahydropyran-4-yl)methyl,

or 2-(4-morpholinyl)ethyl, whether or not further substituted in

the pyrrole ring to any extent, whether or not substituted in the

naphthyl ring to any extent, including:

cycloalkylethyl,

cyanoalkyl,

10

JWH-030;

11

JWH-145;

12

JWH-146;

13

JWH-147;

14

JWH-150;

15

JWH-156;

16

JWH-243;

17

JWH-244;

18

JWH-245;

19

JWH-246;

20

JWH-292;

21

JWH-293;

22

JWH-307;

23

JWH-308;

24

JWH-309;

25

JWH-346;

26

JWH-347;

27

JWH-348;

alkenyl,

(N-methylpiperidin-2-yl)

(N-methylpyrrolidin-2-yl)methyl,
((N-methyl)-3-morpholinyl)methyl,

13

S.B.ANo.A199
1

JWH-363;

JWH-364;

JWH-365;

JWH-366;

JWH-367;

JWH-368;

JWH-369;

JWH-370;

JWH-371;

10

JWH-372;

11

JWH-373; and

12

JWH-392;
naphthylmethylindenes

13

structurally

derived

from

14

1-(1-naphthylmethyl)indene with or without [by] substitution at

15

the 3-position of the indene ring by alkyl, haloalkyl, alkenyl,

16

cycloalkylmethyl,

17

methyl,

18

(tetrahydropyran-4-yl)methyl,

19

or 2-(4-morpholinyl)ethyl, whether or not further substituted in

20

the indene ring to any extent, whether or not substituted in the

21

naphthyl ring to any extent, including:

cycloalkylethyl,

cyanoalkyl,

(N-methylpyrrolidin-2-yl)methyl,

22

JWH-171;

23

JWH-172;

24

JWH-173; and

25

JWH-176;

26

phenylacetylindoles

27

3-phenylacetylindole

with

(N-methylpiperidin-2-yl)

or

((N-methyl)-3-morpholinyl)methyl,

structurally
without

14

[by]

derived

substitution

from
at

the

S.B.ANo.A199
1

nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl,

cycloalkylmethyl,

methyl,

(tetrahydropyran-4-yl)methyl,

or 2-(4-morpholinyl)ethyl, whether or not further substituted in

the indole ring to any extent, whether or not substituted in the

phenyl ring to any extent, including:

cycloalkylethyl,

cyanoalkyl,

AM-694;

AM-1241;

10

JWH-167;

11

JWH-203;

12

JWH-204;

13

JWH-205;

14

JWH-206;

15

JWH-208;

16

JWH-237;

17

JWH-248;

18

JWH-249;

19

JWH-250;

20

JWH-251;

21

JWH-252;

22

JWH-253;

23

JWH-302;

24

JWH-303;

25

JWH-305;

26

JWH-306;

27

JWH-311;

(N-methylpiperidin-2-yl)

(N-methylpyrrolidin-2-yl)methyl,
((N-methyl)-3-morpholinyl)methyl,

15

S.B.ANo.A199
1

JWH-312;

JWH-313;

JWH-314; and

JWH-315;
cyclohexylphenols

structurally

derived

from

2-(3-hydroxycyclohexyl)phenol with or without [by] substitution at

the 5-position of the phenolic ring by alkyl, haloalkyl,

cycloalkylmethyl,

methyl,

cycloalkylethyl,

cyanoalkyl,

(N-methylpiperidin-2-yl)

(N-methylpyrrolidin-2-yl)methyl,

10

(tetrahydropyran-4-yl)methyl,

11

or

12

cyclohexyl ring to any extent, including:

2-(4-morpholinyl)ethyl,

alkenyl,

((N-methyl)-3-morpholinyl)methyl,

whether

or

not

substituted

in

the

13

CP-55,940;

14

CP-47,497;

15

analogues of CP-47,497, including VII, V, VIII, I,

16

II, III, IV, IX, X, XI, XII, XIII, XV, and XVI;

17

JWH-337;

18

JWH-344;

19

JWH-345; and

20

JWH-405; [and]

21

benzoylindoles

structurally

derived

from

22

3-(1-naphthoyl)indole with or without substitution at the nitrogen

23

atom

24

cycloalkylmethyl,

25

methyl,

26

(tetrahydropyran-4-yl)methyl,

27

or 2-(4-morpholinyl)ethyl, whether or not further substituted in

of

the

indole

ring

with

alkyl,

cycloalkylethyl,

cyanoalkyl,

haloalkyl,

alkenyl,

(N-methylpiperidin-2-yl)

(N-methylpyrrolidin-2-yl)methyl,
((N-methyl)-3-morpholinyl)methyl,

16

S.B.ANo.A199
1

the indole ring to any extent, whether or not substituted in the

phenyl ring to any extent, including:

1-pentyl-3-(4-methoxybenzoyl)indole (RCS-4); and

1-[2-(4-morpholinyl)ethyl]-2-methyl-3-(4-

methoxybenzoyl)indole (Pravadoline or WIN 48,098); and

cannabinol

including

derivatives,
tetrahydro

except

where

marihuana,

3-alkyl homologues of cannabinol or of its tetrahydro derivatives,

such as:
Nabilone;

11

HU-210;

12

HU-211; and

13

WIN-55,212-2.

14
15
16

SECTIONA4.AASection

481.106,

Health

of

and

cannabinol

in

10

derivatives

contained

Safety

Code,

and

is

amended to read as follows:

Sec.A481.106.AACLASSIFICATION

OF

CONTROLLED

SUBSTANCE

17

ANALOGUE.

For the purposes of the prosecution of an offense under

18

this subchapter involving the manufacture, delivery, or possession

19

of a controlled substance, Penalty Groups 1, 1-A, [and] 2, and 2-A

20

include a controlled substance analogue that:

21

(1)AAhas a chemical structure substantially similar to

22

the chemical structure of a controlled substance listed in the

23

applicable penalty group; or

24

(2)AAis

specifically

designed

to

produce

an

effect

25

substantially similar to, or greater than, a controlled substance

26

listed in the applicable penalty group.

27

SECTIONA5.AAThe change in law made by this Act applies only

17

S.B.ANo.A199
1

to an offense committed on or after the effective date of this Act.

An

governed by the law in effect on the date the offense was committed,

and the former law is continued in effect for that purpose.

For

purposes

the

effective date of this Act if any element of the offense occurred

before that date.

offense

of

committed

this

before

section,

the

an

effective

offense

was

date

of

committed

this

before

SECTIONA6.AAThis Act takes effect September 1, 2015.

18

Act

is